Opportunities for nanomaterials in enzyme therapy

Возможности применения наноматериалов в ферментной терапии
Jesús M. de la Fuente, Valeria Grazú, Ilaria Armenia, Lorena Betancor, Beatriz Torres‐Herrero, Cecilia Ortiz
2024-06-29

enzyme replacement therapyenzyme therapynanomaterialsnanoparticle-based solutionstherapeutic enzymes
In recent years, enzyme therapy strategies have rapidly evolved to catalyze essential biochemical reactions with therapeutic potential. These approaches hold particular promise in addressing rare genetic disorders, cancer treatment, neurodegenerative conditions, wound healing, inflammation management, and infectious disease control, among others. There are several primary reasons for the utilization of enzymes as therapeutics: their substrate specificity, their biological compatibility, and their ability to generate a high number of product molecules per enzyme unit. These features have encouraged their application in enzyme replacement therapy where the enzyme serves as the therapeutic agent to rectify abnormal metabolic and physiological processes, enzyme prodrug therapy where the enzyme initiates a clinical effect by activating prodrugs, and enzyme dynamic or starving therapy where the enzyme acts upon host substrate molecules. Currently, there are >20 commercialized products based on therapeutic enzymes, but approval rates are considerably lower than other biologicals. This has stimulated nanobiotechnology in the last years to develop nanoparticle-based solutions that integrate therapeutic enzymes. This approach aims to enhance stability, prevent rapid clearance, reduce immunogenicity, and even enable spatio-temporal activation of the therapeutic catalyst. This comprehensive review delves into emerging trends in the application of therapeutic enzymes, with a particular emphasis on the synergistic opportunities presented by incorporating enzymes into nanomaterials. Such integration holds the promise of enhancing existing therapies or even paving the way for innovative nanotherapeutic approaches.
1
Enzyme therapies exploit substrate specificity, biocompatibility, and catalytic turnover for applications in genetic disorders, cancer, neurodegeneration, wound healing, inflammation, and infections.
2
Enzyme–nanomaterial combinations may enhance existing treatments and enable new nanotherapeutic strategies.
3
More than 20 therapeutic enzyme products are commercialized, but their approval rates remain substantially lower than those of other biological therapies.
4
Nanoparticle integration is being developed to improve enzyme stability, reduce rapid clearance and immunogenicity, and enable spatiotemporal control of catalytic activity.
5
Therapeutic enzymes are used in enzyme replacement, enzyme prodrug, and enzyme dynamic or starving therapies to correct or alter pathological processes.

therapeutic enzymes incorporated into nanomaterials

opportunities to enhance enzyme-therapy performance through nanomaterial integration, including improved stability, reduced clearance and immunogenicity, and spatiotemporal activation

Publication Details
Publication Date
2024-06-29
Journal
Publisher
ISSN
Cited by
40
Access Type
Author Information
Authors
Jesús M. de la Fuente
Valeria Grazú
Ilaria Armenia
Lorena Betancor
Beatriz Torres‐Herrero
Cecilia Ortiz
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%